Statements (27)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
|
| gptkbp:alsoKnownAs |
gptkb:Thrombolytics
|
| gptkbp:antidote |
gptkb:Aminocaproic_acid
gptkb:Tranexamic_acid |
| gptkbp:category |
Antithrombotic agents
|
| gptkbp:commonHealthIssues |
gptkb:Alteplase
gptkb:Reteplase gptkb:Streptokinase gptkb:Tenecteplase Urokinase |
| gptkbp:compatibleWith |
Hemorrhagic stroke
|
| gptkbp:contraindication |
Active internal bleeding
History of hemorrhagic stroke |
| gptkbp:discoveredIn |
20th century
|
| https://www.w3.org/2000/01/rdf-schema#label |
Fibrinolytics
|
| gptkbp:indication |
gptkb:Acute_myocardial_infarction
Pulmonary embolism Ischemic stroke |
| gptkbp:mechanismOfAction |
Activate plasminogen
Convert plasminogen to plasmin |
| gptkbp:regulates |
gptkb:FDA
|
| gptkbp:routeOfAdministration |
Intravenous
|
| gptkbp:sideEffect |
Allergic reactions
Bleeding |
| gptkbp:usedFor |
Dissolving blood clots
|
| gptkbp:bfsParent |
gptkb:Thrombolytics
|
| gptkbp:bfsLayer |
7
|